JACK HENRY & ASSOCIATES INC financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data JACK HENRY & ASSOCIATES INC files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026
Revenue	1,431	1,537	1,553	1,697	1,758	1,943	2,078	2,216	2,375	2,544
Cost of revenue	806	853	923	1,008	1,063	1,129	1,219	1,299	1,361	1,434
Gross profit	612	683	630	689	695	814	859	916	1,015	1,111
Research and development	84.8	90.3	96.4	110	109	121	143	148	163	176
Selling, general and administrative	159	172	186	198	187	218	235	278	283	299
Selling and marketing	93.3
General and administrative	69.6
Operating expenses	244
Operating income	342	358	347	381	399	475	481	489	569	635
Interest expense	1	1.92	0.93	0.69	1.14	2.38	15.1
Interest income	0.25	0.58	0.88	1.14	0.15	0.03	8.96
Pre-tax income	341	356	347	381	398	472	475	498	586	653
Income tax	111	-8.88	75.4	84.4	86.3	109	108	116	130	150
Net income	230	365	272	297	311	363	367	382	456	503
EBITDA	391	405	395	433	451	525	529	536	612	677
EPS, basic	2.95	4.73	3.52	3.86	4.12	4.95	5.03	5.24	6.25	7.00
EPS, diluted	2.93	4.70	3.52	3.86	4.12	4.94	5.02	5.23	6.24	6.98
Shares, basic (weighted)	77.9	77.3	77.2	76.8	75.5	73.3	72.9	72.9	72.9	71.9
Shares, diluted (weighted)	78.3	77.6	77.3	76.9	75.7	73.5	73.1	73	73	72
Dividend per share	1.18	1.36	1.54	1.66	1.78	1.90	2.02	2.14	2.26	2.38

Balance sheet

	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026
Cash and equivalents	115	31.4	93.6	213	51	48.8	12.2	38.3	102	12.1
Receivables	277	297	310	301	307	348	361	333	318	349
Other current assets	66.9	96.1	106	95.5	110	126	169	169	180	193
Total current assets	520	471	569	669	544	614	628	632	681	649
Property, plant and equipment	283	286	272	273	252	212	206	215	221	220
Lease right-of-use assets				63.9	56	46.9	43.7	54	44.8	31.8
Goodwill	552	650	667	686	687	687	805	805	805	828
Other non-current assets	82.5	110	135	221	249	294	323	418	444	505
Total assets	1,909	2,033	2,185	2,428	2,336	2,456	2,774	2,924	3,044	3,146
Accounts payable	6.84	30.4	9.85	9.88	18.5	21	19.2	25.3	28.2	34.9
Accrued liabilities	81.6	88.8	120	167	183	192	173	201	207	227
Deferred revenue	383	329	340	318	320	331	332	318	290	295
Short-term debt	0	0	0				0	90	0
Total current liabilities	471	448	470	495	521	544	524	634	536	556
Long-term debt	50	0	0	0.21	100	115	275	60	0
Lease liabilities				56.6	49.4	40.8	40.5	51.2	41.8	28.9
Other non-current liabilities	7.55	12.9	14.3	68.3	59.3	51	54.4	73.6	64.4	53.8
Total liabilities	877	710	756	879	1,017	1,074	1,165	1,082	913	1,094
Total debt	50	0	0	0.21	100	115	275	60	0	40
Paid-in capital	452	464	472	495	519	551	584	620	652	689
Retained earnings	1,585	1,913	2,066	2,235	2,412	2,636	2,856	3,082	3,373	3,705
Treasury stock	-1,006	-1,055	-1,110	-1,182	-1,613	-1,807	-1,832	-1,860	-1,895	-2,343
Shareholders' equity	1,100	1,323	1,429	1,550	1,319	1,382	1,609	1,842	2,131	2,052
Total equity	1,100	1,323	1,429	1,550	1,319	1,382	1,609	1,842	2,131	2,052
Total liabilities and equity	1,909	2,033	2,185	2,428	2,336	2,456	2,774	2,924	3,044	3,146

Cash flow statement

	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026
Net income	230	365	272	297	311	363	367	382	456	503
Depreciation and amortization	49.7	48	47.4	52.2	52.5	50.8	48.7	46.3	43.7	42.1
Stock-based compensation	11.1	11.8	12.6	16.9	20.7	24.8	28.6	28.9	28.4	32.5
Change in receivables	-33.1	21.5	-11.8	10.5	-6.11	-41.5	-12.1	28.2	15.1	-29.3
Change in payables	-7.81	6.92	-7.53	-0.05	-0.09	6.65	-6.28	5.44	2.65	-1.43
Cash from operations	357	412	431	511	462	505	382	568	642	762
Capital expenditures	-41.9	-40.1	-53.6	-53.5	-23	-34.7	-39.2	-58.1	-53.4	-67.1
Acquisitions	0	-138	-20	-30.4	-2.3	0	-230	0	0	-42.4
Purchases of investments	0	-5	0	-1.15	-13.3	-5	-1	-8.65	-2	-13.7
Sales and maturities of investments			0	0	5	0	0	0	1	1
Cash from investing	-142	-292	-191	-198	-162	-196	-410	-240	-232	-278
Debt repaid	-30.2	-175	-35	-55	-100	-317	-650	-600	-500	-440
Stock issued	6.25	7.52	9.04	9.83	10.9	11.8	12.4	12.5	11.7	11.6
Share buybacks	-130	-49	-54.9	-71.5	-432	-194	-25	-28.1	-35.1	-448
Dividends paid	-91.7	-105	-119	-127	-134	-139	-147	-156	-165	-170
Cash from financing	-171	-204	-178	-193	-462	-310	-8.43	-302	-346	-574
Net change in cash	44.5	-83.3	62.2	120	-162	-2.21	-36.5	26	63.7	-89.9
Free cash flow	315	372	378	457	439	470	342	510	588	695
Interest paid	0.77	1.75	0.69	0.48	0.85	1.79	14.8	15.8	10	4.61
Income taxes paid	96.1	60.4	62	63.7	80.2	60.6	146	107	118	38.9

Key metrics

Worked out from the statements above. Latest values use fiscal 2026. Valuation uses the share price of $147.79 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	43.7%	Gross profit / revenue.
Operating margin	25.0%	Operating income / revenue.
EBITDA margin	26.6%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	25.7%	Pre-tax income / revenue.
Net margin	19.8%	Net income / revenue.
FCF margin	27.3%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	29.9%	Cash from operations / revenue.
Effective tax rate	23.0%	Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)	24.0%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	16.2%	Net income / average total assets.
Return on invested capital (ROIC)	23.8%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
R&D / revenue	6.9%	Research and development expense / revenue.
SG&A / revenue	11.8%	Selling, general and administrative expense / revenue.
Stock-based pay / revenue	1.3%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	2.6%	Capital expenditures / revenue.
D&A / revenue	1.7%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	7.1%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	7.0%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	7.7%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	9.5%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	9.0%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	9.8%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y	11.7%	Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y	9.7%	Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y	9.8%	Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y	10.6%	EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y	8.5%	Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y	8.5%	Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y	10.3%	Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y	11.1%	Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y	10.1%	Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS growth, 1y	11.9%	EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y	11.6%	Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 5y	11.1%	Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y	18.8%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	25.9%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y	10.5%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y	18.1%	Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y	26.6%	Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y	9.6%	Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Dividend per share growth, 1y	5.3%	Dividend per share vs the same period a year earlier. Only from a positive base.
Dividend per share CAGR, 3y	5.6%	Compound annual growth of dividend per share over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Dividend per share CAGR, 5y	6.0%	Compound annual growth of dividend per share over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y	-3.7%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	8.5%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	9.2%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	3.3%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	4.3%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	6.1%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	-1.4%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	-0.5%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	-1.0%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	1.17x	Current assets / current liabilities.
Quick ratio	0.65x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.02x	(Cash + short-term investments) / current liabilities.
Debt / equity	0.02x	Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets	1.3%	Total debt / total assets.
Liabilities / assets	34.8%	Total liabilities / total assets.
Net debt	$27.9M	Total debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA	0.04x	Net debt / EBITDA (twelve months), when EBITDA is positive.
Working capital	$92.9M	Current assets - current liabilities.
Goodwill and intangibles / assets	26.3%	(Goodwill + intangible assets) / total assets.
Tangible book value	$1.22B	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	0.82x	Revenue / average total assets.
Fixed asset turnover	11.5x	Revenue / average property, plant and equipment.
Receivables turnover	7.63x	Revenue / average receivables.
Days sales outstanding	48 days	365 x average receivables / revenue.
Days payables	8 days	365 x average accounts payable / cost of revenue.
FCF conversion	138.2%	Free cash flow / net income, when net income is positive.
Capex / operating cash flow	8.8%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	$6.98	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
EPS, basic	$7.00	Net income per basic share, as reported (split-adjusted).
Revenue per share	$35.32	Revenue / diluted weighted shares.
FCF per share	$9.65	Free cash flow / diluted weighted shares.
Operating cash flow per share	$10.58	Cash from operations / diluted weighted shares.
Book value per share	$28.48	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	$16.99	Tangible book value / shares outstanding.
Cash per share	$0.17	(Cash + short-term investments) / shares outstanding.
Dividend per share	$2.38	Dividend declared per common share (paid, when declared is not tagged).
Payout ratio	33.9%	Dividends paid / net income, when net income is positive.
Dividends / FCF	24.5%	Dividends paid / free cash flow, when free cash flow is positive.
Buybacks / FCF	64.5%	Share buybacks / free cash flow, when free cash flow is positive.

Valuation

Metric	Value	How it is calculated
Market cap	$10.50B	Share price x shares outstanding.
Enterprise value	$10.53B	Market cap + total debt - cash - short-term investments.
P/E	20.9x	Market cap / net income. Only when net income is positive.
P/S	4.13x	Market cap / revenue.
P/B	5.12x	Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book	8.58x	Market cap / tangible book value, when positive.
P/FCF	15.1x	Market cap / free cash flow. Only when free cash flow is positive.
P/OCF	13.8x	Market cap / cash from operations, when positive.
EV/Sales	4.14x	Enterprise value / revenue.
EV/EBIT	16.6x	Enterprise value / operating income, when both are positive.
EV/EBITDA	15.5x	Enterprise value / EBITDA, when both are positive.
EV/FCF	15.2x	Enterprise value / free cash flow, when both are positive.
FCF yield	6.6%	Free cash flow / market cap.
Earnings yield	4.8%	Net income / market cap (the inverse of P/E).
Dividend yield	1.6%	Dividends paid over the period / market cap.
Shareholder yield	5.9%	(Dividends paid + share buybacks) / market cap.
PEG	1.80x	P/E / EPS growth per year over 3 years (in percent). Only when both are positive.

What was JACK HENRY & ASSOCIATES INC's revenue in fiscal 2026?

JACK HENRY & ASSOCIATES INC reported revenue of $2.54B for fiscal 2026, 7.1% higher than the year before.

Was JACK HENRY & ASSOCIATES INC profitable in fiscal 2026?

Yes. Net income was $502.8M, a net margin of 19.8%.

How much free cash flow did JACK HENRY & ASSOCIATES INC generate in fiscal 2026?

Cash from operations of $762.0M minus capital expenditures of $67.1M left free cash flow of $694.9M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to JACK HENRY & ASSOCIATES INC